ARS Pharmaceuticals
SPRY
#5972
Rank
โ‚ฌ0.84 B
Marketcap
8,59ย โ‚ฌ
Share price
0.70%
Change (1 day)
-31.84%
Change (1 year)

Revenue for ARS Pharmaceuticals (SPRY)

Revenue in 2025 (TTM): โ‚ฌ0.13 Billion

According to ARS Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. In 2024 the company made a revenue of โ‚ฌ85.66 Million an increase over the revenue in the year 2023 that were of โ‚ฌ0.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ARS Pharmaceuticals from 2022 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.13 B53.61%
2024 โ‚ฌ85.66 M315581.01%
2023 โ‚ฌ0.02 M-97.79%
2022 โ‚ฌ1.22 M